Rare diseases
Investigational molecules
Locations
469 conditions with trials, the busiest first
1 123 trials across Europe, recruiting first
Study on Stopping Solifenacin and Mirabegron for Children with Daytime Urinary Incontinence
DenmarkStudy of IPN01194 for Adults with Advanced Solid Tumors, Including Melanoma, Head and Neck Cancer, Pancreatic Cancer, and Colorectal Cancer
FranceStudy on the Effects of Dirocaftor, Posenacaftor, and Nesolicaftor for Adults with Cystic Fibrosis
BelgiumStudy of Pembrolizumab with Chemotherapy for Patients with Advanced Gastric or Gastroesophageal Junction Cancer
CzechiaStudy on the Safety and Effectiveness of Apraglutide for Patients with Steroid-Resistant Gastrointestinal Acute Graft Versus Host Disease
GermanyStudy of Zolbetuximab Alone and with Drug Combination for Patients with Advanced Stomach or Gastroesophageal Junction Cancer
FranceStudy of JK08, Pembrolizumab, and Lenvatinib for Patients with Advanced or Metastatic Cancer
BelgiumStudy on the Effects of Oxygen Therapy with Vedolizumab, Ustekinumab, or Infliximab for Adults with Moderate to Severe Ulcerative Colitis
PolandStudy on the Safety and Activity of S095029 and Pembrolizumab for Patients with Advanced Gastric or Gastroesophageal Junction Cancer
AustriaStudy of Retifanlimab, Carboplatin, and Paclitaxel for Patients with Inoperable or Metastatic Anal Canal Squamous Cell Carcinoma Not Treated with Chemotherapy
BelgiumStudy on Belapectin for Preventing Esophageal Varices in Patients with NASH Cirrhosis
BelgiumStudy on Irinotecan, Fluorouracil, Oxaliplatin, and Calcium Folinate for Patients with Resectable Stomach and Gastroesophageal Junction Cancer
NorwayThe therapies tested most often in Gastrointestinal disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
